Correlation of placental pathology with the postoperative outcomes and white matter injury in preterm infants following necrotizing enterocolitis

Abstract

BACKGROUND:

To determine the association of placental pathologic lesions with postoperative outcomes, survival, and white matter injury (WMI) in preterm infants with NEC.

METHODS:

A retrospective chart review of 107 neonates with NEC (Bell stage > IIa) from Jan 2013- June 2020 was completed. Demographic, clinical, and outcome data were compared between infants with or without placental pathologic lesions.

RESULTS:

In this cohort, 59/107 (55%) infants had medical NEC, and 48 (45%) had surgical NEC. The infants had a mean gestational age of 28.1±3.7 weeks and a birth weight of 1103±647 g. Maternal vascular malperfusion (82/107, 76.6%) and acute histological chorioamnionitis (42, 39.3%) were the most common pathological placental lesions. Acute histologic chorioamnionitis with fetal inflammatory response was more common in infants with surgical NEC vs. medical NEC (35.4% vs. 15.3%; p = 0.02). The NEC Infants with WMI on brain MRI scans had a significantly higher incidence of acute histological chorioamnionitis (52% vs. 27.8%; P = 0.04). No significant differences in mortality, length of stay and postoperative outcomes in neonates with and without acute histologic chorioamnionitis with fetal inflammatory response were noted. On unadjusted logistic regression, acute histologic chorioamnionitis without fetal inflammatory response was also associated with higher odds of WMI (OR 2.81; 95% CI 1.05–7.54; p = 0.039).

CONCLUSION:

Acute histological chorioamnionitis without fetal inflammatory response was associated with higher odds of WMI in infants with NEC, with no significant impact on mortality and other postoperative outcomes.

Keywords

Necrotizing enterocolitis preterm infants placental pathology white matter injury

1. Introduction

Necrotizing enterocolitis (NEC) affects ∼5–10% of preterm infants with a birth weight≤1500 grams [1, 2]. Despite advances in neonatal intensive care, NEC remains a leading reason for surgical intervention, severe clinical course, and mortality in neonates born preterm [3 –7]. The need for surgical intervention in NEC is associated with increased resource utilization and cost of care due to prolonged hospitalization [8, 9]. The risk factors associated with NEC are complex and multifactorial, including preterm birth, adverse intrauterine environment (inflammatory/hypoxic) and poor perinatal transition [10]. Intrauterine exposure to inflammatory/hypoxic stimuli may prime fetus’s innate immunity cells to a reactive phenotype with exaggerated production of proinflammatory cytokines triggered by risk factors such as formula feeds, blood transfusion, infection, etc., associated with NEC (double-Hit) [10]. Placental histopathologic examination can give us good insights into the intrauterine environment as well as maternal and fetal health but has been under-utilized for bedside clinical decision-making [11, 12].

Some recent studies have reported that the presence of placental fetal vascular malperfusion lesions, placental infarcts, acute histological chorioamnionitis with evidence of fetal inflammatory response is associated with increased frequency of NEC in preterm infants [13 –15]. Our group also reported that infants with multiple placental histopathologic lesions, including inflammatory and vascular lesions, are at increased risk of developing NEC in the postnatal period [16]. However, the impact of the placental histopathologic lesions on postoperative outcomes and white matter injury following surgical NEC has not been studied. We hypothesize placental histopathologic lesions may be associated with worse clinical outcomes in preterm infants diagnosed with NEC. The specific aim of this study was to determine the correlation of placental histopathologic lesions with postoperative outcomes and white matter injury on brain MRI scans in preterm infants following medical and surgical NEC, by using a uniform Amsterdam consensus statement classification of placental histopathology [17].

2. Methods

This retrospective cohort study was conducted at the University of Mississippi Medical Center (UMMC) in Jackson, Mississippi, after approval by the Institutional Review Board (2017–0127). UMMC has a Level 4 neonatal intensive care unit and a regional referral center for neonates with advanced NEC for the entire state. A detailed review of the electronic medical records identified 284 patients with medical and surgical NEC (Bell stage 2 and above) who underwent management of NEC between January 2013 and June 2020. After excluding 29 infants who had duplicate clinical data and 148 infants with missing placental pathology information due to being outborn, we identified 107 infants who were eligible for this study (Fig. 1).

Fig. 1

Patient flow diagram of enrolled patients.

2.1. Clinical information

We recorded demographic characteristics including birth weight, gestational age (GA), sex, race (African American, Caucasian, or Latino), mode of delivery (cesarean section or vaginal delivery), APGAR score at 5 minutes, out-born status and small for gestational age status. We also collected information regarding maternal factors, including pregnancy-induced hypertension, clinical chorioamnionitis, and antenatal steroids.

2.2. NEC data

Infants who did not show obvious pneumatosis intestinalis on abdominal radiographs were classified as≥stage 2 NEC only if they displayed highly suggestive clinical signs with loss of bowel sounds, including generalized abdominal tenderness, abdominal distension, systemic instability with increased needs for respiratory and hemodynamic support, and radiological evidence of intestinal dilatation, fixed bowel loops and/or portal venous gas on abdominal X-ray. We noted the NEC features such as the age of NEC onset (in days), pneumatosis, and clinical presentation (abdominal distension, feeding intolerance, and bloody stools).

We collected information on clinical variables including patent ductus arteriosus (PDA), PDA treatment (medical or surgical), C-reactive protein (CRP) values after NEC onset, cholestasis (direct bilirubin > 2 mg/dL), blood cultures drawn at the time of NEC onset, duration of antibiotic therapy after onset, use of inotropes at 24 hours, and need for assisted ventilation. We also recorded post-operative information on duration of infant not receiving any enteral feeds (Postoperative ileus), day of resuming feeds after surgery, days on parenteral nutrition, the time to reach full enteral feedings (120 mL/kg/day), and intestinal failure (need for parenteral nutrition≥90 days following intestine resection). We also gathered information on length of stay defined as the total duration of hospitalization from the day of admission until discharge or death and mortality defined as death due to any cause before the hospital discharge.

2.3. Placental pathology

A board-certified pediatric pathologist routinely examines placentas from all preterm births at our institution for gross and histologic findings. The umbilical cord, membranes, and placental disc are inspected for any gross abnormalities. The placentas are weighed after removing the umbilical cord, fetal membranes, and non-adherent blood clots. Placental weight below the 10th percentile for estimated GA is considered small for GA, and those weighing > 90^th percentile for GA are considered large for GA [18]. The placental disk is then serially sectioned at 1-2 cm intervals and examined for intraparenchymal lesions. Representative sections of the umbilical cord, fetal membranes, placental parenchyma, and any abnormalities seen on gross examination are submitted for standard histological examination.

Based on the Amsterdam Placental Workshop Group Consensus Statement recommendations, the histopathologic abnormalities assessed were divided into the following subcategories [17]:

Acute histologic chorioamnionitis with or without fetal inflammatory response [19].

Chronic villitis with or without obliterative fetal vasculopathy.

Maternal vascular malperfusion (MVM) including maternal vascular lesions (decidual arteriopathy, mural hypertrophy, incomplete transformation of spiral arteries, and decidual necrosis), infarcts, hemorrhage or hematoma, thrombi, villous changes (chorangiosis, syncytial knots, distal villous hypoplasia, and accelerated villous maturation), and placental hypoplasia [20 –22].

Fetal vascular malperfusion (FVM).

Other inflammatory lesions (chronic deciduitis with plasma cells, massive chronic intervillositis, perivillous fibrin, and histiocytic intervillositis), delayed villous maturation, and villous edema [23].

The presence of more than one of the defined placental lesions was classified as multiple placental pathologies. A representative set of placentas (n = 30) were randomly chosen by a pediatric pathologist and reassessed using the previous noted definitions. This pathologist was blinded to the existing placental reports, clinical history, and patient outcomes. Notably, there was 93% concordance.

Study patients were divided into three groups based on placental pathology: (1) no placental pathology, (2) single placental pathology, and (3) multiple placental pathologic lesions (presence of≥2 histopathologic lesions).

2.4. Neonatal MRI and white matter injury (WMI) data

MRI brain scans are routinely obtained at term equivalent age or before discharge home at UMMC for all preterm infants weighing less than 1500 grams at birth. The MRI images were scored independently by two pediatric neuroradiologists, who are unaware of the infants’ clinical course. We used the scoring system reported by Woodward, et al., that consists of eight 3-point scales (10,17). White-matter abnormality was graded according to five scales, which assessed the nature and extent of white-matter signal abnormality, the loss in the volume of periventricular white matter, and the extent of any cystic abnormalities, ventricular dilatation, or the thinning of the corpus callosum. Composite white-matter scores were created and used to categorize infants according to the extent of their cerebral abnormalities. The categories of white-matter abnormality were none (a score of 5 to 6), mild (a score of 7 to 9), moderate (a score of 10 to 12), and severe (a score of 13 to 15).

2.5. Statistical methods

For normally distributed continuous variables, we summarized the data as mean and standard deviation (±SD) and comparisons between groups were performed using Student’s t-test and analysis of variance for multiple groups (ANOVA). For continuous variables exhibiting skewed distribution, differences in the data were tested using Mann-Whitney U test or Kruskal-Wallis test. Categorical data were summarized as counts with relative frequencies as percentages and differences in the groups were analyzed using Chi-squared test (χ² test) or Fisher’s exact test. First, we performed a univariate logistic regression analysis to examine the crude association between significant placental lesions and the clinical outcomes. Following this, an adjusted model was developed using the variables in the univariate logistic regression and then a multivariate logistic regression analysis was carried out. To avoid the multi collinearity, GA was not included in the model since it exhibited a significant positive correlation with BW. A p-value < 0.05 was considered statistically significant for all the analysis. All the statistical analyses were performed in SPSS software (version 27).

3. Results

We reviewed the medical charts and placental pathology reports of 107 inborn infants with a diagnosis of medical or surgical necrotizing enterocolitis (Fig. 1). Their mean GA was 28.1±3.7 weeks, with a mean birth weight of 1103±647 g. The cohort of infants was predominantly African American (n = 81, 77%), male (n = 58, 54.2%) and born by cesarean delivery (n = 86, 80.4%) (Table 1).

Table 1
Clinical and demographic characteristics of cohort

Available N Combined cohort Medical NEC Surgical NEC p value^**

N = 107 N = 59 N = 48

Prenatal information

Pregnancy-induced hypertension, n (%) 106 44 (41.5) ^* 26 (44.1) 18 (38.3) 0.55

Clinical chorioamnionitis, n (%) 106 10 (9.4) 6 (10.2) 4 (8.5) 1.00

Chronic hypertension 106 25 (23.6) 13 (22.0) 12 (25.5) 0.67

Antenatal steroids, n (%) 103 77 (74.8) 45 (76.3) 32 (72.7) 0.68

Infant demographics

Gestational age (weeks; median (IQR 25th, 75th) 28 (25, 31)^† 28 (26, 32) 26 (24, 30) 0.02

Birth weight (grams; median (25th, 75th) 920 (650, 1570) 1040 (700, 1660) 725 (593, 1285) 0.02

Small for gestational age, n (%) 64 (61.5) 36 (64.3) 28 (58.3) 0.53

Male gender, n (%) 107 58 (54.2) 32 (54.2) 26 (54.2) 0.99

Ethnicity 105 0.97

Caucasian 19 (18.1) 10 (17.2) 9 (19.1)

Hispanic 2 (1.9) 1 (1.7) 1 (2.1)

African American 81 (77.1) 45 (77.6) 36 (76.6)

Others 3 (2.9) 2 (3.4) 1 (2.1)

Mode of delivery 107 0.08

C-section 86 (80.4) 51 (86.4) 35 (72.9)

Vaginal 21 (19.6) 8 (13.6) 13 (27.1)

Apgar score < 6 at 5 minutes 105 26 (24.8) 10 (17.2) 16 (34.0) 0.04

Patent ductus arteriosus, n (%) 106 50 (47.2) 21 (36.2) 29 (60.4) 0.01

Patent ductus arteriosus, indomethacin treated, n (%) 103 19 (18.4) 11 (20.0) 8 (16.7) 0.66

NEC disease features

Age at NEC onset (days; median (25th, 75th) 17 (8, 30) 22 (11, 30) 13 (5, 25) 0.02

Clinical presentation 106 0.02

Abdominal distension, n (%) 73 (68.9) 34 (57.6) 39 (83.0)

Bloody stools, n (%) 26 (24.5) 20 (33.9) 6 (12.8)

Feeding intolerance, n (%) 7 (6.6) 5 (8.5) 2 (4.3)

Radiological findings

Pneumatosis, n (%) 105 53 (50.5) 32 (56.1) 21 (43.8) 0.21

Portal venous gas, n (%) 105 8 (7.6) 3 (5.3) 5 (10.4) 0.47

Assisted ventilation (intubated), n (%) 106 3 (2.8) 1 (1.7) 2 (4.2) 0.59

24h dopamine support, n (%) 103 44 (42.7) 12 (21.4) 32 (68.1) < 0.001

Positive blood culture sepsis, n (%) 107 22 (20.6) 9 (15.3) 13 (27.1) 0.13

Duration of parenteral nutrition (days; median (25th, 75th) 55 (31, 91) 34 (22, 44) 77 (52, 113) < 0.001

White matter injury on MRI brain 79 25 (31.6) 11 (23.4) 14 (43.8) 0.06

Cholestasis at time of NEC onset 82 29 (35.4) 7 (16.3) 22 (56.4) < 0.001

Length of stay (days; median (25th, 75th) 90 (44, 134) 75 (39, 107) 121 (73, 180) < 0.001

Death, n (%) 106 23 (21.7) 8 (13.6) 15 (31.9) 0.02

	Available N	Combined cohort	Medical NEC	Surgical NEC	p value^**
Prenatal information
Pregnancy-induced hypertension, n (%)	106	44 (41.5) ^*	26 (44.1)	18 (38.3)	0.55
Clinical chorioamnionitis, n (%)	106	10 (9.4)	6 (10.2)	4 (8.5)	1.00
Chronic hypertension	106	25 (23.6)	13 (22.0)	12 (25.5)	0.67
Antenatal steroids, n (%)	103	77 (74.8)	45 (76.3)	32 (72.7)	0.68
Infant demographics
Gestational age (weeks; median (IQR 25th, 75th)		28 (25, 31)^†	28 (26, 32)	26 (24, 30)	0.02
Birth weight (grams; median (25th, 75th)		920 (650, 1570)	1040 (700, 1660)	725 (593, 1285)	0.02
Small for gestational age, n (%)		64 (61.5)	36 (64.3)	28 (58.3)	0.53
Male gender, n (%)	107	58 (54.2)	32 (54.2)	26 (54.2)	0.99
Ethnicity	105	0.97
Caucasian		19 (18.1)	10 (17.2)	9 (19.1)
Hispanic		2 (1.9)	1 (1.7)	1 (2.1)
African American		81 (77.1)	45 (77.6)	36 (76.6)
Others		3 (2.9)	2 (3.4)	1 (2.1)
Mode of delivery	107	0.08
C-section		86 (80.4)	51 (86.4)	35 (72.9)
Vaginal		21 (19.6)	8 (13.6)	13 (27.1)
Apgar score < 6 at 5 minutes	105	26 (24.8)	10 (17.2)	16 (34.0)	0.04
Patent ductus arteriosus, n (%)	106	50 (47.2)	21 (36.2)	29 (60.4)	0.01
Patent ductus arteriosus, indomethacin treated, n (%)	103	19 (18.4)	11 (20.0)	8 (16.7)	0.66
NEC disease features
Age at NEC onset (days; median (25th, 75th)		17 (8, 30)	22 (11, 30)	13 (5, 25)	0.02
Clinical presentation	106	0.02
Abdominal distension, n (%)		73 (68.9)	34 (57.6)	39 (83.0)
Bloody stools, n (%)		26 (24.5)	20 (33.9)	6 (12.8)
Feeding intolerance, n (%)		7 (6.6)	5 (8.5)	2 (4.3)
Radiological findings
Pneumatosis, n (%)	105	53 (50.5)	32 (56.1)	21 (43.8)	0.21
Portal venous gas, n (%)	105	8 (7.6)	3 (5.3)	5 (10.4)	0.47
Assisted ventilation (intubated), n (%)	106	3 (2.8)	1 (1.7)	2 (4.2)	0.59
24h dopamine support, n (%)	103	44 (42.7)	12 (21.4)	32 (68.1)	< 0.001
Positive blood culture sepsis, n (%)	107	22 (20.6)	9 (15.3)	13 (27.1)	0.13
Duration of parenteral nutrition (days; median (25th, 75th)		55 (31, 91)	34 (22, 44)	77 (52, 113)	< 0.001
White matter injury on MRI brain	79	25 (31.6)	11 (23.4)	14 (43.8)	0.06
Cholestasis at time of NEC onset	82	29 (35.4)	7 (16.3)	22 (56.4)	< 0.001
Length of stay (days; median (25th, 75th)		90 (44, 134)	75 (39, 107)	121 (73, 180)	< 0.001
Death, n (%)	106	23 (21.7)	8 (13.6)	15 (31.9)	0.02

N is the number of patients in the column and the number in parenthesis is the percent of patients. ^†Values are the median and 25^th, 75^th centiles. ^**Data analyzed by Fisher exact or χ² test; medians analyzed using Mann-Whitney U-test. P-values compare values for Medical and Surgical NEC cases.

The median age of NEC onset was 17 days (IQR 8, 30). Seventy-three neonates (68.9%) had abdominal distension as the presenting symptom. The abdominal x-ray showed pneumatosis in fifty-three (50.5%) and portal venous gas in eight (7.6%) cases. The blood culture obtained at the time of NEC onset was positive in twenty-two (20.6%) infants. Cholestasis (direct bilirubin > 2 mg/dL) at any time following NEC onset was seen in twenty-nine (35.4%) infants. The mean length of hospital stay was 90 (IQR 44, 134) days, and twenty-five neonates (31.6%) had WMI on the brain MRI at term equivalent age. Twenty-three neonates (21.7%) died in our study cohort.

Fifty-nine neonates (55%) had medical NEC and 48 (45%) had surgical NEC. The neonates with surgical NEC had significantly lower median GA (26 wks. [IQR 24, 30] vs. 28 [IQR 26, 32]; p = 0.02), lower birth weight [IQR 725 gm (593, 1285) vs. 1040 gm (IQR 700, 1660); p = 0.02], and more likely to have a patent ductus arteriosus (60.4% vs 36.2%; p = 0.01), 24 hours dopamine support (68.1% vs 21.4%; p < 0.001), extended days on parenteral nutrition (77 days [52, 113] vs. 34 [22, 44]; p < 0.001) and cholestasis (56.4 vs 16.3; p < 0.001). Neonates with surgical NEC had significantly longer length of stay (121 days [73, 180] vs. 75 [39, 107]; p < 0.001) and higher mortality (31.9 vs 13.6; p = 0.02). The occurrence of WMI on brain MRI was higher (43.8% vs. 23.4%) in neonates with surgical NEC. The demographic and clinical information are summarized in Table 1.

3.1. Placental pathology

In our institution, the baseline incidence of acute histologic chorioamnionitis is 9.6% (Vermont Oxford network hospitals – median 7 [IQR 1.8,15.1]) and maternal hypertension 69.6% (Vermont Oxford network hospitals median- 34.8 [26.1,42.3]). In this cohort of preterm infants with NEC, maternal vascular malperfusion (82/107, 76.6%) was the most common placental histopathologic lesions followed by acute histological chorioamnionitis (42, 39.3%). Acute histologic chorioamnionitis with fetal inflammatory response was seen in the placentas from 26 (24.3%) neonates. Fifty-three neonates (49.5%) had multiple placental pathologic lesions and 48 (44.9%) neonates had single placental pathologic lesions. The incidence of other placental pathologic lesions is summarized in Table 2. Neonates with surgical NEC were twice as likely to have acute chorioamnionitis with fetal inflammatory response than neonates with medical NEC (35.4% vs 15.3%; p = 0.02). The occurrence of other lesions did not different between the two groups (Table 2).

Table 2
Placental pathology characteristics of cohort

N Combined cohort Medical NEC Surgical NEC P-value^**

N = 59 N = 48

Multiple placental pathologies 107 53 (49.5)^* 29 (49.2) 24 (50) 0.93

Only 1 placental pathology 107 48 (44.9) 26 (44.1) 22 (45.8) 0.86

SGA placenta 107 20 (18.7) 12 (20.3) 8 (16.7) 0.63

LGA placenta 107 3 (2.8) 1(1.7) 2 (4.2) 0.59

Acute histologic chorioamnionitis 107 42 (39.3) 19 (32.2) 23 (47.9) 0.10

Acute histologic chorioamnionitis with fetal response 107 26(24.3) 9 (15.3) 17 (35.4) 0.02

Villous edema 107 9 (8.4) 5 (8.5) 4 (8.3) 1

High-grade villitis 107 0 0 0

Maternal vascular malperfusion 107 82 (76.6) 48 (81.4) 34 (70.8) 0.20

Fetal vascular malperfusion 107 7 (6.5) 3 (5.1) 4 (8.3) 0.7

Chronic chorioamnionitis 107 1 (0.9) 1 (1.7) 0 1

	N	Combined cohort	Medical NEC	Surgical NEC	P-value^**
Multiple placental pathologies	107	53 (49.5)^*	29 (49.2)	24 (50)	0.93
Only 1 placental pathology	107	48 (44.9)	26 (44.1)	22 (45.8)	0.86
SGA placenta	107	20 (18.7)	12 (20.3)	8 (16.7)	0.63
LGA placenta	107	3 (2.8)	1(1.7)	2 (4.2)	0.59
Acute histologic chorioamnionitis	107	42 (39.3)	19 (32.2)	23 (47.9)	0.10
Acute histologic chorioamnionitis with fetal response	107	26(24.3)	9 (15.3)	17 (35.4)	0.02
Villous edema	107	9 (8.4)	5 (8.5)	4 (8.3)	1
High-grade villitis	107	0	0	0
Maternal vascular malperfusion	107	82 (76.6)	48 (81.4)	34 (70.8)	0.20
Fetal vascular malperfusion	107	7 (6.5)	3 (5.1)	4 (8.3)	0.7
Chronic chorioamnionitis	107	1 (0.9)	1 (1.7)	0	1

^*The data are presented as the number of neonates in the column with values in parenthesis as the percent of total in the column. ^**P values compare Medical and Surgical NEC using Fisher exact or χ² test used for analysis.

3.2. Clinical outcomes

On subgroup analysis, we compared the clinical and demographic information between the two groups neonates with surgical NEC based on acute histologic chorioamnionitis with and without fetal inflammatory response. We did not any find any significant clinical and demographic differences except for lower rate of pregnancy-induced hypertension and cesarean section rate in neonates with acute histologic chorioamnionitis with fetal response. The data are summarized inTable 3.

Table 3
Clinical differences in neonates with and without chorioamnionitis with fetal response in surgical NEC

Combined cohort Chorioamnionitis with fetal response No chorioamnionitis with fetal response P value^*

N = 17 N = 31

Prenatal information

Pregnancy-induced hypertension, n (%) 47 18 (38.3)^# 2 (11.8) 16 (53.3) 0.005

Chronic hypertension, n (%) 47 12 (25.5) 4 (23.5) 8 (26.7) 0.81

Antenatal steroids, n (%) 44 32 (72.7) 12 (75) 20 (71.4) 0.79

Infant demographics

Gestational age (weeks; mean±SD)^† 48 27.2±3.7^† 25.8±2.3 28±4 0.14

Birth weight (grams; mean±SD) 48 975±651 812±370 1064±754 0.64

Male gender, n (%) 48 26 (54.2) 8 (47.1) 18 (58.1) 0.46

Ethnicity, n (%) 47 0.7

Caucasian 9 (19.1) 4 (23.5) 5 (16.7)

Hispanic 1 (2.1) 0 1 (3.3)

African American 36 (76.6) 13 (76.5) 23 (76.7)

Others 1 (2.1) 0 1 (3.3)

Small for gestational age, n (%) 48 28 (58.3) 13 (76.5) 15 (48.4) 0.059

Mode of delivery, n (%) 48 0.003

C-section 35 (72.9) 8 (47.1) 27 (87.1)

Vaginal 13 (27.1) 9 (52.9) 4 (12.9)

Apgar score < 6 at 5 mins, n (%) 47 16 (34) 5 (31.3) 11(35.5) 0.77

Patent ductus arteriosus, n (%) 48 29 (60.4) 10 (58.8) 19 (61.3) 0.86

Patent ductus arteriosus, indomethacin treated, n (%) 48 8 (16.7) 4 (23.5) 4 (12.9) 0.42

NEC disease features

Age at NEC onset (days; mean±SD) 18.8±17.4 21±15 17±18 0.34

Clinical presentation 47 0.53

Abdominal distension, n (%) 39 (83) 15 (88.2) 24 (80)

Bloody stools, n (%) 6 (12.7) 2 (11.8) 4 (13.3)

Feeding intolerance, n (%) 2 (4.3) 0 2 (6.7)

Radiological findings

Pneumatosis, n (%) 48 21 (43.8) 7 (41.2) 21 (45.2) 0.79

Portal venous gas, n (%) 48 5 (10.4) 1 (5.9) 4 (12.9) 0.64

Pneumoperitoneum 48 24 (50) 9 (52.9) 15 (48.4) 0.76

Fulminant NEC, n (%) 48 11 (22.9) 4 (23.5) 7 (22.6) 0.94

length of bowel resected (cm,mean±SD) 46 17±16 22.1±18.1 14±14.2 0.14

Region of bowel resected, n (%) 41 0.69

Small intestine 28 (68.3) 11 (73.3) 17 (65.4)

large intestine 1 (2.4) 0 1 (3.8)

Both large and small intestine 12 (29.3) 4 (26.7) 8 (30.8)

Cholestasis any time following NEC, n (%) 39 22 (56.4) 10 (66.7) 12 (50) 0.3

Intestinal failure, n (%) 40 22 (55) 10 (66.7) 12 (48) 0.25

Assisted ventilation (intubated), n (%)

24h dopamine support, n (%) 47 32 (68.1) 22 (71) 10 (62.5) 0.55

Positive blood culture sepsis, n (%) 48 13 (27.1) 6 (35.3) 7 (22.6) 0.34

Duration of parenteral nutrition (days; mean±SD) 88±53 99±54 82±52 0.26

Length of stay (days; mean±SD) 136±87 162±93 122±83 0.15

Death, n (%) 47 15 (31.9) 5 (29.4) 10(33.3) 0.78

White matter injury on MRI, n (%) 32 14 (43.8) 5 (50) 9 (40.9) 0.63

		Combined cohort	Chorioamnionitis with fetal response	No chorioamnionitis with fetal response	P value^*
Prenatal information
Pregnancy-induced hypertension, n (%)	47	18 (38.3)^#	2 (11.8)	16 (53.3)	0.005
Chronic hypertension, n (%)	47	12 (25.5)	4 (23.5)	8 (26.7)	0.81
Antenatal steroids, n (%)	44	32 (72.7)	12 (75)	20 (71.4)	0.79
Infant demographics
Gestational age (weeks; mean±SD)^†	48	27.2±3.7^†	25.8±2.3	28±4	0.14
Birth weight (grams; mean±SD)	48	975±651	812±370	1064±754	0.64
Male gender, n (%)	48	26 (54.2)	8 (47.1)	18 (58.1)	0.46
Ethnicity, n (%)	47				0.7
Caucasian		9 (19.1)	4 (23.5)	5 (16.7)
Hispanic		1 (2.1)	0	1 (3.3)
African American		36 (76.6)	13 (76.5)	23 (76.7)
Others		1 (2.1)	0	1 (3.3)
Small for gestational age, n (%)	48	28 (58.3)	13 (76.5)	15 (48.4)	0.059
Mode of delivery, n (%)	48				0.003
C-section		35 (72.9)	8 (47.1)	27 (87.1)
Vaginal		13 (27.1)	9 (52.9)	4 (12.9)
Apgar score < 6 at 5 mins, n (%)	47	16 (34)	5 (31.3)	11(35.5)	0.77
Patent ductus arteriosus, n (%)	48	29 (60.4)	10 (58.8)	19 (61.3)	0.86
Patent ductus arteriosus, indomethacin treated, n (%)	48	8 (16.7)	4 (23.5)	4 (12.9)	0.42
NEC disease features
Age at NEC onset (days; mean±SD)		18.8±17.4	21±15	17±18	0.34
Clinical presentation	47				0.53
Abdominal distension, n (%)		39 (83)	15 (88.2)	24 (80)
Bloody stools, n (%)		6 (12.7)	2 (11.8)	4 (13.3)
Feeding intolerance, n (%)		2 (4.3)	0	2 (6.7)
Radiological findings
Pneumatosis, n (%)	48	21 (43.8)	7 (41.2)	21 (45.2)	0.79
Portal venous gas, n (%)	48	5 (10.4)	1 (5.9)	4 (12.9)	0.64
Pneumoperitoneum	48	24 (50)	9 (52.9)	15 (48.4)	0.76
Fulminant NEC, n (%)	48	11 (22.9)	4 (23.5)	7 (22.6)	0.94
length of bowel resected (cm,mean±SD)	46	17±16	22.1±18.1	14±14.2	0.14
Region of bowel resected, n (%)	41				0.69
Small intestine		28 (68.3)	11 (73.3)	17 (65.4)
large intestine		1 (2.4)	0	1 (3.8)
Both large and small intestine		12 (29.3)	4 (26.7)	8 (30.8)
Cholestasis any time following NEC, n (%)	39	22 (56.4)	10 (66.7)	12 (50)	0.3
Intestinal failure, n (%)	40	22 (55)	10 (66.7)	12 (48)	0.25
Assisted ventilation (intubated), n (%)
24h dopamine support, n (%)	47	32 (68.1)	22 (71)	10 (62.5)	0.55
Positive blood culture sepsis, n (%)	48	13 (27.1)	6 (35.3)	7 (22.6)	0.34
Duration of parenteral nutrition (days; mean±SD)		88±53	99±54	82±52	0.26
Length of stay (days; mean±SD)		136±87	162±93	122±83	0.15
Death, n (%)	47	15 (31.9)	5 (29.4)	10(33.3)	0.78
White matter injury on MRI, n (%)	32	14 (43.8)	5 (50)	9 (40.9)	0.63

^#N is the number of patients in the column and the number in parenthesis is the percent of patients. ^†Values are the mean and 25^th, 75^th centiles. Data analyzed by Fisher exact or χ² test; student t-test. ^*P-values compare values for chorioamnionitis with and without response in neonates with Surgical NEC.

3.3. Placental pathology and death

When we compared the placental pathology in non- survivors (23, 21.4%) and survivors (84, 88.6%). There was no association between placental histopathology and death in preterm infants with NEC (Table 4).

Table 4
Placental findings in survivors vs. non - survivors

Death Alive P-value

N = 23 N = 84

Multiple placental pathologies, n (%) ^* 53 (49.5) 12 (52.2) 41 (48.8) 0.78

Only 1 placental pathology, n (%) 48 (44.9) 11 (47.8) 37 (44.0) 0.75

SGA placenta, n (%) 19 (17.8) 6 (26.1) 13 (15.5) 0.24

LGA placenta, n (%) 3 (2.8) 0 3 (3.6) 1.00

Acute histologic chorioamnionitis 43 (40.2) 11 (47.8) 32 (38.1) 0.4

Acute histologic chorioamnionitis with fetal inflammatory response, n (%) 26(24.3) 5 (21.7) 21 (25.0) 0.75

Villous edema, n (%) 9 (8.4) 2 (8.7) 7 (8.3) 1.00

High-grade villitis, n (%) 0 0 0

Maternal vascular malperfusion, n (%) 82 (76.6) 18 (78.3) 64 (76.2) 0.84

Fetal vascular malperfusion, n (%) 8 (7.5) 2 (8.7) 6 (7.1) 0.68

Chronic chorioamnionitis, n (%) 1 (0.9) 0 1 (1.2) 1.00

		Death	Alive	P-value
Multiple placental pathologies, n (%) ^*	53 (49.5)	12 (52.2)	41 (48.8)	0.78
Only 1 placental pathology, n (%)	48 (44.9)	11 (47.8)	37 (44.0)	0.75
SGA placenta, n (%)	19 (17.8)	6 (26.1)	13 (15.5)	0.24
LGA placenta, n (%)	3 (2.8)	0	3 (3.6)	1.00
Acute histologic chorioamnionitis	43 (40.2)	11 (47.8)	32 (38.1)	0.4
Acute histologic chorioamnionitis with fetal inflammatory response, n (%)	26(24.3)	5 (21.7)	21 (25.0)	0.75
Villous edema, n (%)	9 (8.4)	2 (8.7)	7 (8.3)	1.00
High-grade villitis, n (%)	0	0	0
Maternal vascular malperfusion, n (%)	82 (76.6)	18 (78.3)	64 (76.2)	0.84
Fetal vascular malperfusion, n (%)	8 (7.5)	2 (8.7)	6 (7.1)	0.68
Chronic chorioamnionitis, n (%)	1 (0.9)	0	1 (1.2)	1.00

^*n (%) is the number of patients in the column and the number in parenthesis is the percent of patients. Data analyzed by Fisher exact or χ² test; P-values compare values for death and alive neonates with surgical NEC.

3.4. Placental pathology and white matter injury

In our study population, seventy-nine infants qualified for term equivalent MRI brain scans. The 25/79 infants (31.6%) had WMI and were compared with neonates without WMI (54/79, 68.3%). WMI was associated with a significantly higher incidence of acute histologic chorioamnionitis as compared to infants without WMI on brain MRI (52% vs 27.8%; p = 0.04). No other placental pathologic lesion was significantly associated with WMI in the two groups of neonates with NEC (Table 5).

Table 5
Placental pathology in neonates with and without white matter injury in neonates with medical and surgical NEC

Cohort (N) no WMI WMI p value^**

N = 79 N = 54 N = 25

Multiple placental pathologies, n (%) ^* 37 (46.8) 26 (48.1) 11(44.0) 0.73

Only 1 placental pathology, n (%) 37 (46.8) 25 (46.3) 12(48.0) 0.89

SGA placenta, n (%) 16 (20.3) 13 (24.1) 3 (12.0) 0.21

LGA placenta, n (%) 2 (2.5) 2 (3.7) 0 1.00

Acute histologic chorioamnionitis, n (%) 28 (35.4) 15 (27.8) 13 (52.0) 0.04

Acute histologic chorioamnionitis with fetal inflammatory response, n (%) 17 (21.5) 10 (18.5) 7 (28.0) 0.34

Villous edema, n (%) 6 (7.6) 5 (9.3) 1 (4.0) 0.66

High-grade villitis, n (%) 0 0 0

Maternal vascular malperfusion, n (%) 59 (74.7) 42 (77.8) 17 (68.0) 0.35

Fetal vascular malperfusion, n (%) 4 (5.1) 3 (5.6) 1 (4.0) 1.00

Chronic chorioamnionitis, n (%) 1 (1.3) 1 (1.9) 0 1.00

	Cohort (N)	no WMI	WMI	p value^**
Multiple placental pathologies, n (%) ^*	37 (46.8)	26 (48.1)	11(44.0)	0.73
Only 1 placental pathology, n (%)	37 (46.8)	25 (46.3)	12(48.0)	0.89
SGA placenta, n (%)	16 (20.3)	13 (24.1)	3 (12.0)	0.21
LGA placenta, n (%)	2 (2.5)	2 (3.7)	0	1.00
Acute histologic chorioamnionitis, n (%)	28 (35.4)	15 (27.8)	13 (52.0)	0.04
Acute histologic chorioamnionitis with fetal inflammatory response, n (%)	17 (21.5)	10 (18.5)	7 (28.0)	0.34
Villous edema, n (%)	6 (7.6)	5 (9.3)	1 (4.0)	0.66
High-grade villitis, n (%)	0	0	0
Maternal vascular malperfusion, n (%)	59 (74.7)	42 (77.8)	17 (68.0)	0.35
Fetal vascular malperfusion, n (%)	4 (5.1)	3 (5.6)	1 (4.0)	1.00
Chronic chorioamnionitis, n (%)	1 (1.3)	1 (1.9)	0	1.00

^*n (%) is the number of patients in the column and the number in parenthesis is the percent of patients. Data analyzed by Fisher exact or χ² test; ^**P-values compare values for with and without white matter injury in neonates with surgical and medical NEC.

On unadjusted logistic regression, acute histologic chorioamnionitis without fetal inflammatory response was also associated with higher odds of WMI (OR 2.81; 95% CI 1.05–7.54; p = 0.039). However, on adjusted logistic regression, acute histologic chorioamnionitis without fetal inflammatory response was not significantly associated with higher odds of WMI (OR 2.68; 95% CI 0.98–7.32; p = 0.055; Table 6).

Table 6

Multivariate logistic regression analysis for WMI

	Unadjusted analysis
				95% CI.for EXP(B)
	B	Sig.	Exp(B)	Lower	Upper
Chorioamnionitis with fetal response	0.53	0.34	1.711	0.564	5.196
Acute histological chorioamnionitis	1.03	0.039	2.817	1.052	7.542
	Adjusted analysis
Chorioamnionitis with fetal response^*	0.44	0.438	1.567	0.503	4.882
Acute histological chorioamnionitis^*	0.98	0.05	2.680	0.981	7.324

^*Adjusted for birth weight.

4. Discussion

The association of placental pathology with the clinical outcomes in preterm infants with NEC is poorly studied. In our cohort of preterm infants with NEC, we noted that infants with surgical NEC had poor clinical outcomes. When we examined placental pathologic lesions, acute histologic chorioamnionitis was associated with increased odds of surgical NEC, but had no significant effect on postoperative outcomes, length of stay or death before discharge from the hospital. However, acute histologic chorioamnionitis was associated with the presence of WMI on MRI brain scans in infants diagnosed with NEC. These observations suggest an association between prenatal exposure to acute intrauterine inflammation and the pathogenesis, severity, and clinical outcomes of NEC in preterm infants.

Our study suggests that placental inflammation with evidence of a fetal response may place the fetal intestine at greater risk of subsequent injury, when exposed to NEC-related stimuli such as formula feeds, sepsis, or platelet/red blood transfusions after birth. Thus, supporting the double hit model hypothesis for surgical NEC [10]. Placental pathologic evidence of a fetal inflammatory response includes the presence of fetal neutrophils within the muscular walls of veins and/or arteries in the chorioamniotic plate and/or umbilical cord [24, 25]. Cute histologic chorioamnionitis with fetal inflammatory response is associated with systemic inflammatory responses in the fetal circulation in the form of an exaggerated proinflammatory cytokine response [26]. Intrauterine exposure to proinflammatory cytokines may switch the fetal innate immunity cells, such as macrophages, to a reactive phenotype (priming). Such sensitized cells can sustain an exaggerated production of proinflammatory cytokines when reconfronted with renewed postnatal inflammatory stimuli(two-hit hypothesis). The development of fibrin deposition in response to endothelial damage of the placental vasculature due to vasculitis may form part of the mechanism linking chorioamnionitis with a fetal response and postnatal development of NEC or intestinal injury [27, 28]. Many investigators have reported an association between activation of inflammatory pathways in the fetal circulation via cytokines and subsequent neonatal morbidity and mortality [27 , 29–31]. Satar, et al. [29] reported that infants with NEC had higher IL-8 levels in their umbilical cord blood when compared to those without NEC (p < 0.05). In another study, elevated levels of IL-6 in umbilical cord blood predicted early-onset sepsis in preterm neonates, suggesting the role of an altered intrauterine environment affecting the fetus and subsequent postnatal outcomes [30]. The higher levels of cytokines in mixed umbilical cord blood in these studies could be fetal or maternal/placental in origin. It is notable that we reported that proinflammatory cytokines (IL-6, and IL-8) increase in the umbilical arterial blood during normal parturition in uncomplicated term pregnancies [32]. Thus, the inflammatory cytokines IL-6 and -8 are derived from the fetus and not either the mother or placenta. Moreover, there was 100% non-saturable placental clearance over the range of blood concentrations measured [32]. In a recently published study, we observed that in the presence of clinical chorioamnionitis, there is marked elevation in the umbilical arterial concentrations of IL-6 and IL-8, and placental clearance falls to 65%, not only demonstrating a fetal source, but also concentration-dependent clearance with saturation of the clearance mechanisms at very high concentrations [33]. However, these findings need to be studied further to make conclusions about the source of cytokines in umbilical cord blood in pregnancies complicated bychorioamnionitis.

In our study, infants with NEC were more likely to have evidence of WMI on brain MRI scans, which may also be related to the enhanced fetal inflammatory responses and the subsequent postnatal inflammatory surge secondary to the development of surgical NEC [34 –37]. Salas et al. reported that subacute necrotizing funisitis (risk ratio 1.87; 95% CI, 1.04–3.35; P = 0.04) and chorionic plate vasculitis with thrombosis (risk ratio 2.21; 95% CI, 1.10–4.46; P = 0.03) were associated with severe neurodevelopmental impairment/death [34]. Korzeniewski et al. proposed a multi-hit model of neonatal WMI, suggesting that chronic placental inflammation, acute fetal inflammation, and postnatal inflammatory conditions such as surgical NEC might contribute to the risk for WMI and/or directly damage the developing brain of neonates delivered very preterm [38, 39]. In contrast, Bierstone, et al., did not find an association between histologic chorioamnionitis and WMI or cognitive or motor neurodevelopmental outcome at 18 to 24 months corrected age after accounting for perinatal factors [40]. Of interest, Niño, et al., studying a mouse model of NEC identified a gut-brain signaling pathway in which activation of intestinal TLR4 signaling led to release of high-mobility group box 1 in the intestine that, in turn, promoted microglial activation in the brain and neurological dysfunction [35].

To our knowledge, this is the first study to examine the impact of placental histologic pathology in preterm infants on postoperative outcomes and brain injury following NEC in a predominantly African American population using a uniform classification of placental pathologic lesions. We acknowledge that our study is limited by its single-center and retrospective design. The relatively small sample size may also reduce the generalizability of the study outcomes and the statistical power to detect associations between histopathology and NEC. MRI brain scans of only ∼73% of the patient population was available, and that might have biased theresults.

In conclusion, in this single center retrospective cohort of predominantly African American preterm infants with NEC, acute histologic chorioamnionitis was associated with WMI on brain MRI at term equivalent age. However, there were no significant effects on postoperative recovery, length of stay or mortality. In addition, infants with WMI on MRI brain scans obtained at term equivalence also had a greater incidence of acute histologic chorioamnionitis. In the future, prospective multi-center studies, which include additional clinical, maternal and laboratory predictors, such as fetal and neonatal serum inflammatory biomarkers, may improve our understanding of the mechanisms associated with the presence of prenatal placental pathology and the subsequent development of NEC and its impact on postoperative and brain injury outcomes. There is need to better understand the inflammatory surge and response in postnatal life to identify the at-risk infants for surgical NEC timely and develop better immunomodulatory approach for theseinfants.

Author contribution

P.M. Garg designed, collected, analyzed, and wrote the manuscript.

J. Paschal: Collected/analyzed the data and wrote the manuscript. M.A.Y Ansari: Analyzed the data and wrote the manuscript. Jennifer Ware, Kristin Adams, Charlotte Taylor, Kartik Reddy, Charles R. Rosenfeld, Imran N. Mir collected and analyzed the data and wrote the manuscript.

All authors approved the manuscript.

Funding

Dr. Parvesh Garg is partially supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 5U54GM115428. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Consent

Patient consent was not required for de-identified retrospective data.

Footnotes

Acknowledgments

We would like to thank Dr. Redline from Case Western University and Dr. Suhas Kallapur from UCLA for all the guidance for the project.

Conflicts of interest

The authors disclose no conflicts.

References

Neu

, Walker

. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–264.

Sankaran

, Puckett

, Lee

, Seshia

, Boulton

, Qiu

, . Canadian Neonatal Network. Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr. 2004;39(4):366–372.

Sjoberg Bexelius

, Ahle

, Elfvin

, Björling

, Ludvigsson

, Andersson

. Intestinal failure after necrotising enterocolitis: Incidence and risk factors in a Swedish population-based longitudinal study. BMJ Paediatr Open. 2018;2(1):e000316.

Allin

BSR

, Long

, Gupta

, Lakhoo

, Knight

. British Association of Paediatric Surgeons Congenital Anomalies Surveillance System Necrotising Enterocolitis Collaboration. One-year outcomes following surgery for necrotising enterocolitis: A UK-wide cohort study. Arch Dis Child Fetal Neonatal Ed. 2018;103(5):F461–F466.

Knell

, Han

, Jaksic

, Modi

. Current Status of Necrotizing Enterocolitis. Curr Probl Surg. 2019;56(1):11–38.

Stoll

, Hansen

, Bell

, Walsh

, Carlo

, Shankaran

, . Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA. 2015;314(10):1039–1051.

Sántulli

, Schullinger

, Heird

, Gongaware

, Wigger

, Barlow

, . Acute necrotizing enterocolitis in infancy: A review of 64 cases. Pediatrics. 1975;55(3):376–387.

Mowitz

, Dukhovny

, Zupancic

JAF

. The cost of necrotizing enterocolitis in premature infants. Semin Fetal Neonatal Med. 2018;23(6):416–419.

Ganapathy

, Hay

, Kim

, Lee

, Rechtman

. Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: A retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC Pediatr. 2013;13:127.

10.

Garzoni

, Faure

, Frasch

. Fetal cholinergic anti-inflammatory pathway and necrotizing enterocolitis: the brain-gut connection begins in utero. Front Integr Neurosci. 2013;7:57.

11.

Keating

, El-Osta

. Epigenetics and metabolism. Circ Res. 2015;116(4):715–736.

12.

Nelissen

, van Montfoort

, Dumoulin

, Evers

. Epigenetics and the placenta. Hum Reprod Update. 2011;17(3):397–417.

13.

Moore

, Arnold

, Wright

. Necrotizing enterocolitis and the placenta - a key etiological link. J Pediatr Surg. 2013;48(2):359–362.

14.

Dix

, Roth-Kleiner

, Osterheld

. Placental vascular obstructive lesions: Risk factor for developing necrotizing enterocolitis. Patholog Res Int. 2010;2010:838–917.

15.

Been

, Lievense

, Zimmermann

, Kramer

, Wolfs

. Chorioamnionitis as a risk factor for necrotizing enterocolitis: A systematic review and meta-analysis. J Pediatr. 2013;162(2):236–242.e2

16.

Garg

, Paschal

, Ansari

MAY

, Billington

, Ware

, Adams

, . Association of placental pathologic findings with the severity of necrotizing enterocolitis in preterm infants - A matched case-control study. Fetal Pediatr Pathol. 2022;1–11.

17.

Khong

, Mooney

, Ariel

, Balmus

, Boyd

, Brundler

, . Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698–713.

18.

Pinar

, Sung

, Oyer

, Singer

. Reference values for singleton and twin placental weights. Pediatr Pathol Lab Med. 1996;16(6):901–907.

19.

Houben

, Nikkels

, van Bleek

, Visser

, Rovers

, Kessel

, . The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One. 2009;4(8):e6572.

20.

Fitzgerald

, Kingdom

, Keating

. Distal villous hypoplasia. Diagn Histopathol. 2012;18(5):195–200.

21.

Stevens

, de Nobrega Teixeira

, Spaanderman

MEA

, Bulten

, van Vugt

JMG

, Al-Nasiry

. Understanding decidual vasculopathy and the link to preeclampsia: A review. Placenta. 2020;97:95–100.

22.

Ernst

. Maternal vascular malperfusion of the placental bed. APMIS. 2018;126(7):551–560.

23.

Khong

, Mooney

, Nikkels

PGJ

, Morgan

, Gordijn

. Pathology of the placenta: A practical guide. Cham: Springer; 2019.

24.

Redline

, Heller

, Keating

, Kingdom

. Placental diagnostic criteria and clinical correlation–a workshop report. Placenta. (2005;26(Suppl A):S114–S117.

25.

Redline

, Minich

, Taylor

, Hack

. Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (< 1 kg). Pediatr Dev Pathol. 2007;10(4):282–292.

26.

Kim

, Yoon

, Romero

, Moon

, Kim

, Park

, . Umbilical arteritis and phlebitis mark different stages of the fetal inflammatory response. Am J Obstet Gynecol. 2001;185(2):496–500.

27.

Ducey

, Owen

, Coombs

, Cohen

. Vasculitis as part of the fetal response to acute chorioamnionitis likely plays a role in the development of necrotizing enterocolitis and spontaneous intestinal perforation in premature neonates. Eur J Pediatr Surg. 2015;25(3):284–291.

28.

Dammann

, Allred

, Leviton

, Shen-Schwarz

, Heller

, Genest

, . Fetal vasculitis in preterm newborns: Interrelationships, modifiers, and antecedents. Placenta. 2004;25(10):788–796.

29.

Satar

, Turhan

, Yapicioglu

, Narli

, Ozgunen

, Cetiner

. Cord blood cytokine levels in neonates born to mothers with prolonged premature rupture of membranes and its relationship with morbidity and mortality. Eur Cytokine Netw. 2008;19(1):37–41.

30.

Hatzidaki

, Gourgiotis

, Manoura

, Korakaki

, Bossios

, Galanakis

, Giannakopoulou

. Interleukin-6 in preterm premature rupture of membranes as an indicator of neonatal outcome. Acta Obstet Gynecol Scand. 2005;84(7):632–638.

31.

Skrablin

, Lovric

, Banovic

, Kralik

, Dijakovic

, Kalafatic

. Maternal plasma interleukin-6, interleukin-1beta and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery. J Matern Fetal Neonatal Med. 2007;20(4):335–341.

32.

Mir

, Chalak

, Liao

, Johnson-Welch

, Brown

, Longoria

, Savani

, Rosenfeld

. Fetal-placental crosstalk occurs through fetal cytokine synthesis and placental clearance. Placenta. 2018;69:1–8.

33.

Mir

, Uddin

, Liao

, Brown

, Leon

, Chalak

, . Placental clearance not synthesis tempers exaggerated pro-inflammatory cytokine response in neonates exposed to chorioamnionitis. Pediatr Res. 2022.

34.

Salas

, Faye-Petersen

, Sims

, Peralta-Carcelen

, Reilly

, McGwin

Jr , . Histological characteristics of the fetal inflammatory response associated with neurodevelopmental impairment and death in extremely preterm infants. J Pediatr. 2013;163(3):652–657.e1-e2

35.

Niño

, Zhou

, Yamaguchi

, Martin

, Wang

, Fulton

, . Cognitive impairments induced by necrotizingenterocolitis can be prevented by inhibiting microglial activation in mouse brain. Sci Transl Med. 2018;10(471):eaan0237.

36.

Brunse

, Abbaspour

, Sangild

. Brain barrier disruption and region-specific neuronal degeneration during necrotizing enterocolitis in preterm pigs. Dev Neurosci. 2018;40(3):198–208.

37.

Mir

, Johnson-Welch

, Nelson

, Brown

, Rosenfeld

, Chalak

. Placental pathology is associated with severity of neonatal encephalopathy and adverse developmental outcomes following hypothermia. Am J Obstet Gynecol. 2015;213(6):849.e1–849.e7.

38.

Korzeniewski

, Romero

, Cortez

, Pappas

, Schwartz

, Kim

, Yoon

, Chaiworapongsa

, Hassan

. A “multi-hit” model of neonatal white matter injury: cumulative contributions of chronic placental inflammation, acute fetal inflammation and postnatal inflammatory events. J Perinat Med. 2014;42(6):731–743.

39.

Bangma

, Hartwell

, Santos

Jr , O’Shea

, Fry

. Placental programming, perinatal inflammation, and neurodevelopment impairment among those born extremely preterm. Pediatr Res. 2021;89(2):326–335.

40.

Bierstone

, Wagenaar

, Gano

, Guo

, Georgio

, Groenendaal

, . Association of histologic chorioamnionitis with perinatal brain injury and early childhood neurodevelopmental outcomes among preterm neonates. JAMA Pediatr. 2018;172(6):534–541.